Discover new innovative strategies for managing challenging CMV infections post-HSCT presented by Prof. Dr. Johan Maertens. This comprehensive presentation delves into the latest advancements in antiviral therapies and the impact of CMV resistance on patient outcomes, using a practical patient case of 59-year-old man with acute leukemia who experienced multiple CMV reactivations post-transplantation, requiring multiple lines of antiviral treatment.
Download now to gain valuable insights into approaches that are transforming patient care in hematopoietic cell transplantation.
C-ANPROM/BE/LIV/0014 July 2025